99 related articles for article (PubMed ID: 31265453)
1. Validation of the prognostic value of NF-κB p65 in prostate cancer: A retrospective study using a large multi-institutional cohort of the Canadian Prostate Cancer Biomarker Network.
Grosset AA; Ouellet V; Caron C; Fragoso G; Barrès V; Delvoye N; Latour M; Aprikian A; Bergeron A; Chevalier S; Fazli L; Fleshner N; Gleave M; Karakiewicz P; Lacombe L; Lattouf JB; van der Kwast T; Trudel D; Mes-Masson AM; Saad F;
PLoS Med; 2019 Jul; 16(7):e1002847. PubMed ID: 31265453
[TBL] [Abstract][Full Text] [Related]
2. Identification of intraductal carcinoma of the prostate on tissue specimens using Raman micro-spectroscopy: A diagnostic accuracy case-control study with multicohort validation.
Grosset AA; Dallaire F; Nguyen T; Birlea M; Wong J; Daoust F; Roy N; Kougioumoutzakis A; Azzi F; Aubertin K; Kadoury S; Latour M; Albadine R; Prendeville S; Boutros P; Fraser M; Bristow RG; van der Kwast T; Orain M; Brisson H; Benzerdjeb N; Hovington H; Bergeron A; Fradet Y; Têtu B; Saad F; Leblond F; Trudel D
PLoS Med; 2020 Aug; 17(8):e1003281. PubMed ID: 32797086
[TBL] [Abstract][Full Text] [Related]
3. Characterization of RNA-Binding Motif 3 (RBM3) Protein Levels and Nuclear Architecture Changes in Aggressive and Recurrent Prostate Cancer.
Carleton NM; Zhu G; Miller MC; Davis C; Kulkarni P; Veltri RW
Cancer Rep (Hoboken); 2020 Jun; 3(3):e1237. PubMed ID: 32587951
[TBL] [Abstract][Full Text] [Related]
4. Different cellular localization of NF-κB p65 expression as an indicator of different prognoses of stage I-III gastric cancer patients.
Zhou F; Wei H; Ding A; Qiu W; Feng L; Zhou Q; Liang J; Yue L
Clin Transl Sci; 2013 Oct; 6(5):381-5. PubMed ID: 24127926
[TBL] [Abstract][Full Text] [Related]
5. Expression of the microtubule-associated protein 2 (MAP2) as a potential independent prognostic marker in prostate cancer.
Stein J; Krappe E; Kremer A; Cronauer MV; Essler M; Cox A; Klümper N; Krausewitz P; Ellinger J; Ritter M; Kristiansen G; Majores M
J Cancer Res Clin Oncol; 2024 Feb; 150(2):76. PubMed ID: 38310601
[TBL] [Abstract][Full Text] [Related]
6. CYP7B1 as a Biomarker for Prostate Cancer Risk and Progression: Metabolic and Oncogenic Signatures (Diagnostic Immunohistochemistry Analysis by Tissue Microarray in Prostate Cancer Patients-Diamond Study).
Russo GI; Durukan E; Asmundo MG; Lo Giudice A; Salzano S; Cimino S; Rescifina A; Fode M; Abdelhameed AS; Caltabiano R; Broggi G
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731981
[TBL] [Abstract][Full Text] [Related]
7. Discovery of PTN as a serum-based biomarker of pro-metastatic prostate cancer.
Liu S; Shen M; Hsu EC; Zhang CA; Garcia-Marques F; Nolley R; Koul K; Rice MA; Aslan M; Pitteri SJ; Massie C; George A; Brooks JD; Gnanapragasam VJ; Stoyanova T
Br J Cancer; 2021 Mar; 124(5):896-900. PubMed ID: 33288843
[TBL] [Abstract][Full Text] [Related]
8. Genomic and Clinicopathologic Characterization of
Kaur H; Salles DC; Murali S; Hicks JL; Nguyen M; Pritchard CC; De Marzo AM; Lanchbury JS; Trock BJ; Isaacs WB; Timms KM; Antonarakis ES; Lotan TL
Clin Cancer Res; 2020 Sep; 26(18):4869-4881. PubMed ID: 32694154
[TBL] [Abstract][Full Text] [Related]
9. Expression of p52, a non-canonical NF-kappaB transcription factor, is associated with poor ovarian cancer prognosis.
Hufnagel DH; Wilson AJ; Saxon J; Blackwell TS; Watkins J; Khabele D; Crispens MA; Yull FE; Beeghly-Fadiel A
Biomark Res; 2020; 8():45. PubMed ID: 32974032
[TBL] [Abstract][Full Text] [Related]
10. Immune checkpoint-related serum proteins and genetic variants predict outcomes of localized prostate cancer, a cohort study.
Wang Q; Ye Y; Yu H; Lin SH; Tu H; Liang D; Chang DW; Huang M; Wu X
Cancer Immunol Immunother; 2021 Mar; 70(3):701-712. PubMed ID: 32909077
[TBL] [Abstract][Full Text] [Related]
11. Observer performance in the use of digital and optical microscopy for the interpretation of tissue-based biomarkers.
Gavrielides MA; Conway C; O'Flaherty N; Gallas BD; Hewitt SM
Anal Cell Pathol (Amst); 2014; 2014():157308. PubMed ID: 25763314
[TBL] [Abstract][Full Text] [Related]
12. Validation of the systematic scoring of immunohistochemically stained tumour tissue microarrays using QuPath digital image analysis.
Loughrey MB; Bankhead P; Coleman HG; Hagan RS; Craig S; McCorry AMB; Gray RT; McQuaid S; Dunne PD; Hamilton PW; James JA; Salto-Tellez M
Histopathology; 2018 Aug; 73(2):327-338. PubMed ID: 29575153
[TBL] [Abstract][Full Text] [Related]
13. Increased HSF1 expression predicts shorter disease-specific survival of prostate cancer patients following radical prostatectomy.
Björk JK; Ahonen I; Mirtti T; Erickson A; Rannikko A; Bützow A; Nordling S; Lundin J; Lundin M; Sistonen L; Nees M; Åkerfelt M
Oncotarget; 2018 Jul; 9(58):31200-31213. PubMed ID: 30131848
[TBL] [Abstract][Full Text] [Related]
14. Expression of ERBB Family Members as Predictive Markers of Prostate Cancer Progression and Mortality.
Clairefond S; Ouellet V; Péant B; Barrès V; Karakiewicz PI; Mes-Masson AM; Saad F
Cancers (Basel); 2021 Apr; 13(7):. PubMed ID: 33918389
[TBL] [Abstract][Full Text] [Related]
15. Development and Validation of a 28-gene Hypoxia-related Prognostic Signature for Localized Prostate Cancer.
Yang L; Roberts D; Takhar M; Erho N; Bibby BAS; Thiruthaneeswaran N; Bhandari V; Cheng WC; Haider S; McCorry AMB; McArt D; Jain S; Alshalalfa M; Ross A; Schaffer E; Den RB; Jeffrey Karnes R; Klein E; Hoskin PJ; Freedland SJ; Lamb AD; Neal DE; Buffa FM; Bristow RG; Boutros PC; Davicioni E; Choudhury A; West CML
EBioMedicine; 2018 May; 31():182-189. PubMed ID: 29729848
[TBL] [Abstract][Full Text] [Related]
16. The Prognostic Significance of Selected HLA Alleles on Prostate Cancer Outcome.
Stokidis S; Baxevanis CN; Fortis SP
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37833904
[TBL] [Abstract][Full Text] [Related]
17. Morphologic features of prostate cancer-encased native vessels: An image analysis study.
Fernandez Gonzalez De La Vega C; Duenweg S; Jain P; Rubenstein SI; Bobholz S; Barrett MJ; LaViolette PS; Iczkowski KA
Pathol Res Pract; 2024 Apr; 256():155239. PubMed ID: 38461692
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of inflammation in prostate cancer progression and response to therapeutic: a critical review.
Sciarra A; Gentilucci A; Salciccia S; Pierella F; Del Bianco F; Gentile V; Silvestri I; Cattarino S
J Inflamm (Lond); 2016; 13():35. PubMed ID: 27924136
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Significance of Nuclear Factor kappa B (p65) among Breast Cancer Patients in Cape Coast Teaching Hospital.
Barnes P; Mensah A; Derkyi-Kwarteng L; Adankwa E; Agbo E; Yahaya ES; Amoani B; Adjei G; Ka-Chungu SMA; Akakpo PK; Pappoe F; Dankwa K; Amoako-Sakyi D; Nuvor SV; Obiri-Yeboah D; Saahene RO
Med Princ Pract; 2024 May; ():. PubMed ID: 38723618
[TBL] [Abstract][Full Text] [Related]
20. Biomarkers in Prostate Cancer: A Review.
Ahmadieh N; Zeidan T; Chaaya C; Cain D; Aoude M; Abouchahla A; Kourie HR; Nemer E
Gulf J Oncolog; 2024 Jan; 1(44):81-93. PubMed ID: 38205576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
